1)  pedunculated
肝外生长
2)  Extrahepatic
肝外
1.
The diagnosis value of MRCP in the extrahepatic biliary obstruction diseases;
肝外胆管梗阻性疾病的MRCP诊断价值
2.
Experience of gallbladder pedlcule flap graft or intestinum jejunum film to repair the extrahepatic duct dect defect;
带蒂胆囊瓣或空肠壁修补肝外胆管缺损16例报告
3.
The cause of extrahepatic obstructive jaundice diagnosed by CT and MPR after ERCP (an analysis of 24cases);
ERCP后CT及MPR诊断肝外梗阻性黄疸病因(附24例分析)
3)  Liver injury
肝外伤
1.
Liver injury in the abdominal trauma accounting for 5% ~ 20% [1] , case fatality rate of 18.
肝外伤在腹部外伤中占5%~20%[1],病死率达18。
4)  hepatic trauma
肝外伤
1.
Management of 32 severe hepatic traumatic patients(with a report of 32 cases);
严重肝外伤的救治(附32例报告)
2.
Objective: To summarize the clinical features of hepatic trauma.
目的:总结肝外伤的临床特点,提高对肝外伤的诊疗水平。
3.
Methods Forty-nine cases of hepatic trauma undergoing surgical treatment were analyzed in our hospital from Jan.
目的探讨不同术式综合应用对不同程度不同类型肝外伤的治疗效果。
5)  Liver trauma
肝外伤
1.
Postoperative nutritional support of the patients with liver trauma;
肝外伤患者术后营养支持的研究
2.
Hepatectomy for severe liver trauma (report of 12 cases);
肝切除治疗严重肝外伤(附12例报告)
3.
Liver trauma is an usual closed abdominal injury, and easily leads to death.
肝外伤是常见的闭合性腹部外伤,极易导致死亡。
6)  extrahepatic metabolism
肝外代谢
1.
Effects of supplement with glucose on the model rats for the investigation of extrahepatic metabolism;
术后补充葡萄糖对肝外代谢模型大鼠的影响
2.
Objective:To observe the changes of fentanyl pharmacokinetics in rats during anhepatic phase by treatment of large dose of dexamethasone and to investigate the extrahepatic metabolism of fentanyl.
目的:研究大剂量地塞米松处理后大鼠无肝期药代动力学的影响,探讨芬太尼的肝外代谢及地塞米松对其盰外代谢的影响。
3.
Objective To observe the changes of blood fentanyl concentration in rats during anhepatic phase by treatment of large dose of dexamethasone and to investigate the extrahepatic metabolism of fentanyl.
目的揭示大剂量地塞米松处理后大鼠无肝期血药浓度变化规律,探讨芬太尼的肝外代谢及地塞米松对其肝外代谢的影响。
参考词条
补充资料:诺德人体生长激素,基因重组人生长激素,健高买,重组人生长激素
药物名称:重组人生长激素

英文名:Somatropin

别名:诺德人体生长激素,基因重组人生长激素,健高买,重组人生长激素
外文名:Saizen, Norditropin, Genotropin, Norditropin, DNA-rhGH
药理作用:为DNA重组技术生产的人体生长激素,是促进生长的机制之一,能刺激IGF-1和蛋白质合成,促进骨骼和体细胞的生长,利于脂肪分解和蛋白质合成,使肌肉增加,脂肪减少.
适应症:用于内源性生长激素分泌不足或先天性性腺发育不全(特纳综合征)所引起的生长发育障碍,青春期前慢性肾功能不全所引起的生长发育障碍,成人生长激素不足的替代疗法(用于心功能不全等).
注意点:1.配制药液时不可振荡,以免变性.2.每周剂量分7天皮下注射,注射部位应更换,如有一天漏注,则第二天不必倍量补注。3.糖尿病、妊娠、乳母慎用。4.恶性肿瘤术后,对本品过敏者,各种活动性恶性肿瘤禁用。5.不良反应可能会有甲状腺功能减退,液体潴留、伴周围水肿,曾有少数良性颅内高压病例的报告。
用量用法:成人:生长激素不足:0.125iu/(kg.周) 。 先天性子宫发育不全: 1iu/(kg.周),以上剂量均分作7天皮下注射。
规格:针剂:4iu, 10iu, 12iu, 16iu.

类别:生殖系统药/促进子宫成熟药
说明:补充资料仅用于学习参考,请勿用于其它任何用途。